Haleon plc (LON:HLN)

London flag London · Delayed Price · Currency is GBP · Price in GBX
398.40
+9.70 (2.50%)
May 2, 2025, 5:36 PM BST
20.36%
Market Cap 35.92B
Revenue (ttm) 11.23B
Net Income (ttm) 1.44B
Shares Out 9.02B
EPS (ttm) 0.16
PE Ratio 25.38
Forward PE 20.94
Dividend 0.07 (1.66%)
Ex-Dividend Date Apr 24, 2025
Volume 23,542,353
Average Volume 27,630,341
Open 386.00
Previous Close 388.70
Day's Range 386.00 - 405.10
52-Week Range 319.84 - 417.70
Beta 0.23
RSI 61.52
Earnings Date Jul 31, 2025

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprisi... [Read more]

Sector Healthcare
Founded 1715
Employees 24,561
Stock Exchange London Stock Exchange
Ticker Symbol HLN
Full Company Profile

Financial Performance

In 2024, Haleon's revenue was 11.23 billion, a decrease of -0.61% compared to the previous year's 11.30 billion. Earnings were 1.44 billion, an increase of 37.46%.

Financial Statements

News

Haleon plc (HLN) Q1 2025 Earnings Call Transcript

Haleon plc (NYSE:HLN) Q1 2025 Results Conference Call April 30, 2025 3:30 PM ETCompany ParticipantsJo Russell - Head-Investor RelationsDawn Allen - Chief...

3 days ago - Seeking Alpha

Brightseed and Haleon Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation

LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Brightseed and Haleon and Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation.

4 days ago - Business Wire

Consumer healthcare group Haleon raises medium-term profit forecast

Haleon on Thursday raised its medium-term target for profit growth from 2026, banking on strength in key markets and costs cuts within its supply chain, which would save the consumer healthcare group ...

4 days ago - Reuters

Haleon reports lower first-quarter revenue hurt by a weaker flu season

British consumer healthcare group Haleon on Wednesday reported a 2.3% fall in its first-quarter revenue as sluggish demand for its cold and cough medicines outside of North America continued to weigh.

5 days ago - Reuters

Canada Soccer and Haleon Kickoff Multi-Year Partnership focused on Health and Wellness

The partnership marks Haleon Canada's first national, full-portfolio sponsorship TORONTO , April 24, 2025 /CNW/ - Canada Soccer and Haleon Canada announced a new multi-year partnership committed to pr...

11 days ago - Benzinga

UK's Haleon takes full control of Chinese consumer healthcare venture

British consumer healthcare group Haleon said on Tuesday it has gained complete ownership of its Chinese joint venture after acquiring Tianjin Pharmaceutical Da Ren Tang's 12% stake for about 1.62 bil...

20 days ago - Reuters

Sensodyne toothpaste maker Haleon now an independent company after Pfizer sells stake

Shares in the consumer health group - originally a joint venture between Pfizer and GSK - are up nearly a fifth since it joined the stock market in 2022.

6 weeks ago - This is Money

Pfizer offloads final shares in Sensodyne maker Haleon

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer.

6 weeks ago - Evening Standard

Pfizer Sells Remaining Stake in Haleon for $3.25 Billion

Pfizer Sells Remaining Stake in Haleon for $3.25 Billion

6 weeks ago - GuruFocus

Pfizer sells entire Haleon stake for $3.24 billion

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer healthcare firm at 385 pence per share, a bookrunner for t...

6 weeks ago - Reuters

Pfizer to sell remaining stake in Haleon

6 weeks ago - Seeking Alpha

Pfizer to dispose of entire Haleon stake

Haleon shareholder Pfizer will dispose of its entire 7.3% stake in the British consumer healthcare group, a bookrunner said on Tuesday.

6 weeks ago - Reuters

2 Attractively Priced, High Yield Stocks For Income Durability As The Market Hits New Highs

Hyperinflation and high interest rates make dividend-paying stocks attractive, providing cash flow and alleviating inflation pressure. Pfizer's 6% yield is appealing despite recent stock declines, wit...

2 months ago - Seeking Alpha

Haleon: Growing Profits And Dividend

Haleon's dividend grew 10% and is well-covered by FCF, but the 1.6% yield is less attractive compared to peers. See why I rate HLN stock a hold.

2 months ago - Seeking Alpha

Sensodyne Toothpaste Maker Haleon Expects Profit To Be Weighted Towards Second Half Of 2025

London-based consumer healthcare group Haleon Plc (NYSE: HLN) stock is trading lower on Thursday. Haleon, GSK Plc’s (NYSE: GSK) spun off, reported revenue of 11.23 billion pounds (US$14.19 billion) ...

2 months ago - Benzinga

Sensodyne Toothpaste Maker Haleon Expects Profit To Be Weighted Towards Second Half Of 2025

London-based consumer healthcare group Haleon Plc HLN stock is trading lower on Thursday.

2 months ago - Benzinga

Haleon CEO: We're relatively low-exposed to tariffs

Haleon CEO Brian McNamara says his company is not as exposed as peers to tariff risks, as the consumer healthcare company reports full-year results

2 months ago - CNBC International TV

Haleon CEO: We're relatively low-exposed to tariffs

Haleon CEO Brian McNamara says his company is not as exposed as peers to tariff risks, as the consumer healthcare company reports full-year results

2 months ago - CNBC

Haleon Expects Further Growth After Profit Rises

2 months ago - The Wall Street Journal